Skip to content

When to Outsource vs Build a Laboratory

Outsourcing and building are not opposites. Most organizations end up with a deliberate mix — the skill is in choosing which work goes where.

Draft — owner to review

Companies weighing an in-house laboratory often frame the question as cost. Cost matters, but control, speed, expertise and risk usually decide it.

Signals that favor outsourcing

  • Volume is low, irregular or uncertain.
  • The method requires specialized instruments or expertise you would rarely use.
  • Speed to first data matters more than long-run unit cost.

Signals that favor building

  • Testing is core to your product or a competitive differentiator.
  • Volume is high and predictable enough to keep capacity utilized.
  • Turnaround or confidentiality requirements are difficult to contract for.

Outsourcing still carries responsibility

In FDA-regulated drug manufacturing, FDA guidance describes how owners and contract facilities should use written quality agreements to define responsibilities — the owner remains accountable for quality.[1]

When selecting contract testing laboratories, accreditation to ISO/IEC 17025 by an ILAC MRA signatory body offers one independent indicator of competence for the accredited scope.[2][3]

Advisor's analysis

Check the accredited scope, not just the certificate. A laboratory can be accredited for some methods and not the one you need.

A staged path

Many organizations outsource first, learn the method and volume profile, then bring the highest-volume or most strategic work in-house. That sequence reduces the risk of building capacity for demand that never arrives.

→ To source contract laboratories or issue an RFQ for testing services, see LaboratoryVortex.

Sources

  1. [1] U.S. Food and Drug Administration, “Contract Manufacturing Arrangements for Drugs: Quality Agreements — Guidance for Industry.”
  2. [2] International Organization for Standardization, “ISO/IEC 17025:2017 — General requirements for the competence of testing and calibration laboratories.”
  3. [3] International Laboratory Accreditation Cooperation, “ILAC MRA and Signatories.”

Bracketed numbers link to sources. Passages labelled “Advisor's analysis” are interpretation, not cited fact.

Related advisory: Commercialization & Scientist to CEO · Strategic Partnerships & Alliances · FDA Regulatory & Quality Strategy

Scientific services and sourcing

Looking for laboratory capabilities or scientific services rather than a strategic advisory engagement? Explore Laboratory Vortex for sourcing and RFQs.

Explore Laboratory Vortex (opens in a new tab)

These are separate destinations for different needs; links do not imply a formal affiliation, endorsement or Alliance membership.

More founder guides

Begin a conversation

What is your next strategic decision?

Share the opportunity, challenge or investment you are evaluating. Start with a confidential conversation about fit, priorities and scope.

Contact UsRequest a Strategy Call

Start with a confidential inquiry. Strategy calls are arranged individually, not booked automatically.